Attention deficit disorder and hyperactivity. An overview;Trastorno por déficit de atención con hiperactividad. Una visión global

Anales de Pediatria

Volumn 59, Issue 3, 2003, Pages 225-228

  Cardo Jalon E ^a   Servera Barcelo M ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; CLOMIPRAMINE; IMIPRAMINE; METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; CLINICAL FEATURE; COMORBIDITY; DRUG INDICATION; EDITORIAL; HUMAN; NEUROBIOLOGY; PATHOPHYSIOLOGY; PREVALENCE; PSYCHOTHERAPY;

EID: 0742306341     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13050600     Document Type: Editorial

References (26)

1. Barkley RA. Attention-deficit/hyperactivity disorder, self-regulation, and time: Toward a more comprehensive theory. J Dev Behav Pediatr 1997;18:271-9.
2. Still GF. Some abnormal psychological conditions in children. Lancet 1902;1:1008-12.
3. DSM-IV. Manual diagnóstico y estadístico de los trastornos mentales (ed. esp.). Barcelona: Masson, 1995.
4. DSM-IV-TR. Manual diagnóstico y estadístico de los trastornos mentales. Washington: American Psychiatric Association, 2000;85-93.
5. Servera M, Bornas X, Moreno I. Hiperactividad infantil: Conceptualización, evaluación y tratamiento. En: Caballo V, Simón MA, editors. Manual de psicología clínica infantil y del adolescente. Madrid: Ediciones Pirámide, 2001; p. 401-33.
6. Faraone SV, Biederman J, Weber W, Russell R. Psychiatric neuropsychological and psychosocial features of DSM-IV subtypes of attention deficit/hyperactivity disorder: Results from a clinically referred sample. J Am Acad Child Adolesc Psychiatry 1998;37:185-93.
7. Gershon J. A meta-analytic review of gender differences in ADHD. J Atten Disord 2002;5:143-54.
8. Pineda DA, Lopera F, Palacio JD, Ramírez D, Henao GC. Prevalence estimations of atención-deficit/hyperactivity disorder: Differential diagnoses and comorbidities in a Colombian simple. Int J Neurosci 2003;113:49-71.
9. Peña JA, Montiel-Nava C. Trastorno por déficit de atención/hiperactividad: ¿mito o realidad? Rev Neurol 2003;36:173-9.
10. Barkley RA. Issues in the diagnosis of attention-deficit/hyperactivity disorder in children. Brain Dev 2003;25:77-83.
11. Monastra VJ, Lubar JF, Linden M, van Deusen P, Green G, Wing W, et al. Assessing attention deficit hyperactivity disorder via quantitative electroencephalography: An initial validation study. Neuropsychology 1999;13:424-33.
12. Cox DJ, Kovatchev BP, Morris JB Jr, Phillips C, Hill RJ, Merkel L. Electroencephalographic and psychometric differences between boys with and without attentiondeficit/Hyperactivity disorder (ADHD): A pilot study. Appl Psychophysiol Biofeedback 1998;23:179-88.
13. Frazer A, Gerhardt GA, Daws LC. New views of biogenic amine transporter function: Implications for neuropsychopharmacology. Int J Neuropsychopharmacol 1999;2:305-20.
14. Rietveld MJ, Hudziak JJ, Bartels M, Van Beijsterveldt CE, Boomsma DI. Heritability of attention problems in children: I. cross-sectional results from a study of twins, age 3-12 years. Am J Med Genet 2003;15:102-13.
15. Swanson JM, Flodman P, Kennedy J, Spence MA, Moyzis R, Schuck S, et al. Dopamine genes and ADHD. Neurosci Biobehav Rev 2000;24:215.
16. Smith KM, Daly M, Fischer M, Yiannoutsos CT, Bauer L, Barkley R, et al. Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: Genetic analysis of the Milwaukee longitudinal study. Am J Med Genet 2003;15:77-85.
17. Eiraldi RB, Power TJ, Nezu CM. Patterns of comorbidity associated with subtypes of attention-deficit/hyperactivity disorder among 6- to 12-year-old children. J Am Acad Child Adolesc Psychiatry 1997;36:503-14.
18. Connor DF, Edwards G, Fletcher KE, Baird J, Barkley RA, Steingard RJ. Correlates of comorbid psychopathology in children with ADHD. Acad Child Adolesc Psychiatry 2003;42:193-200.
19. Biederman J, Milberger S, Faraone SV, Kiely K, Guite J, Mick E, et al. Impact of adversity on functioning and comorbidity in children with attention-deficit hyperactivity disorder. Impact of adversity on functioning and comorbidity in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995;34:1495-503.
20. Cohen NJ, Douglas VI. Characteristics of the orienting response in hyperactive and normal children. Psychophysiology 1972;9:238-45.
21. Facoetti A, Lorusso ML, Paganoni P, Cattaneo C, Galli R, Umilta C, et al. Auditory and visual automatic attention deficits in developmental dyslexia. Brain Res Cogn Brain Res 2003;16:185-91.
22. Spencer TJ, Biederman J, Wilens TE, Faraone SV. Novel treatments for attention-deficit/hyperactivity disorder in children. J Clin Psychiatry 2002;63:16-22.
23. Vles JS, Feron FJ, Hendriksen JG, Jolles J, Van Kroonenburgh MJ, Weber WE. Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD). Neuropediatrics 2003;34:77-80.
24. Connor DF, Barkley RA, Davis HT. A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clin Pediatr (Phila) 2000;39:15-25.
25. Parr JR, Ward A, Inman S. Current practice in the management of attention deficit disorder with hyperactivity (ADHD). Child Care Health Dev 2003;29:215-8.
26. Simpson D, Perry C. Atomoxetine. Paediatr Drugs 2003;5:407-15.